Screener
Relay Therapeutics, Inc. RLAY Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Relay Therapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338056
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Purchases of property and equipment | — | (410) |
| Purchases of investments | (522,225) | (30,899) |
| Proceeds from maturities and sales of investments | 202,100 | 148,920 |
| Net cash (used in) provided by investing activities | (320,125) | 117,611 |
| Cash flows from financing activities: | ||
| Proceeds from issuance of common stock via at-the-market offerings, net | 159,219 | — |
| Proceeds from issuance of common stock through follow-on offering, net | 296,814 | — |
| Proceeds from issuance of common stock through exercise of stock options | 5,583 | — |
Item 1. Financial Statements.
FAQ
- What is Relay Therapeutics, Inc.'s investing cash flow?
- Relay Therapeutics, Inc. (RLAY) reported investing cash flow of -$353.03M in Q2 2026.
- How has Relay Therapeutics, Inc.'s investing cash flow changed year-over-year?
- Relay Therapeutics, Inc.'s investing cash flow decreased by 569.8% year-over-year, from $75.15M to -$353.03M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Relay Therapeutics, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude